Clene director granted stock options at $6.81

Clene Inc. director Reed N. Wilcox received two stock option grants as equity compensation.

Rhea-AI Filing Summary

Clene Inc. director Reed N. Wilcox received two stock option grants as equity compensation. On May 21, 2026, he was awarded options for 2,064 shares of common stock at an exercise price of $6.81 per share that vest immediately.

On the same date, he was also granted options for 1,500 shares of common stock at the same $6.81 exercise price. These 1,500-share options vest in 12 equal monthly installments on the 21st day of each month beginning June 21, 2026, and both grants were made under the Clene Inc. Amended 2020 Stock Plan.

Insider Trade Summary

Grant/Award: 3,564 shares

Grant/Award 2 txns

Insider WILCOX REED N

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	1,500	$0.00	$0.00
Grant/Award	stock option	2,064	$0.00	$0.00

Holdings After Transaction: stock option — 3,564 contracts (Direct)

Footnotes (2)

1. F1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.
2. F2. This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

Key Figures

Option grant size (immediate vesting): 2,064 options for common stock Option grant size (monthly vesting): 1,500 options for common stock Exercise price: $6.81 per share +2 more

5 metrics

Option grant size (immediate vesting) 2,064 options for common stock Granted May 21, 2026; vest immediately; exercise price $6.81

Option grant size (monthly vesting) 1,500 options for common stock Granted May 21, 2026; vest over 12 months; exercise price $6.81

Exercise price $6.81 per share Applies to both stock option grants

Vesting start date (monthly grant) June 21, 2026 First of 12 equal monthly installments

Option expiration date May 20, 2036 Expiration date for each option grant

Key Terms

stock option, Amended 2020 Stock Plan, exercise price, vest immediately upon grant, +1 more

5 terms

stock option financial

"This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Amended 2020 Stock Plan financial

"under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share"

exercise price financial

"at an exercise price of $6.81 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest immediately upon grant financial

"The options vest immediately upon grant"

vest in 12 equal monthly installments financial

"The options vest in 12 equal monthly installments on the 21st day of each calendar month"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Clene (CLNN) director Reed N. Wilcox report on this Form 4?

He reported receiving two stock option grants as equity compensation. One covers 2,064 shares that vest immediately, and another covers 1,500 shares that vest monthly, both with a $6.81 exercise price under Clene’s Amended 2020 Stock Plan.

How many Clene Inc. stock options did Reed N. Wilcox receive?

He received two separate stock option awards. One grant is for 2,064 underlying common shares that vest immediately, and the other is for 1,500 underlying common shares that vest in 12 monthly installments starting June 21, 2026, subject to the plan terms.

What is the exercise price of the new Clene (CLNN) stock options?

Both option grants have an exercise price of $6.81 per share. This means Wilcox can buy Clene common stock at $6.81 when the options are vested and exercisable, consistent with the terms of the Amended 2020 Stock Plan and each grant’s vesting schedule.

How do the vesting terms differ between Reed N. Wilcox’s Clene option grants?

The 2,064-share option grant vests immediately upon grant. The 1,500-share option grant vests in 12 equal monthly installments on the 21st day of each month, starting June 21, 2026, until all shares covered by that grant are fully vested.

Under what plan were the Clene (CLNN) stock options to Reed N. Wilcox granted?

Both stock option awards were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of the options, including the $6.81 exercise price, vesting schedules, and other conditions tied to Wilcox’s equity-based compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 01:53 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILCOX REED N

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UTAH 84121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$6.81	05/21/2026		A		1,500		(1)	05/20/2036	common stock	1,500	$0	1,500	D
stock option	$6.81	05/21/2026		A		2,064		(2)	05/20/2036	common stock	2,064	$0	2,064	D

Explanation of Responses:

1. This option was granted on May 21, 2026 as an option for 1,500 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest in 12 equal monthly installments on the 21st day of each calendar month, beginning June 21, 2026, until such shares are fully vested.

2. This option was granted on May 21, 2026 as an option for 2,064 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $6.81 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)